Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
38,595,106
-
Share change
-
+2,866,986
-
Total reported value
-
$548,041,984
-
Put/Call ratio
-
53%
-
Price per share
-
$14.20
-
Number of holders
-
120
-
Value change
-
+$48,773,765
-
Number of buys
-
68
-
Number of sells
-
45
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2018
As of 31 Mar 2018 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,595,106 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, FMR LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, BRIDGER MANAGEMENT, LLC, UBS ASSET MANAGEMENT AMERICAS INC, and COLUMBUS CIRCLE INVESTORS.
This table shows 120 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.